Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria, Australia

Hum Vaccin Immunother. 2018;14(8):2088-2092. doi: 10.1080/21645515.2018.1460293. Epub 2018 May 10.

Abstract

Immediate hypersensitivity reactions (IHR) are rare but potentially serious adverse events following immunization (AEFI). Surveillance of Adverse Events following Vaccination in the Community (SAEFVIC) is an enhanced passive surveillance system that collects, analyses and reports information about AEFI in Victoria, Australia. We describe the incidence, timing and type of potential IHR following vaccination in preschool children reported over an 8-year period. A total of 2110 AEFI were reported in 1620 children, of which 23.5% (496) were classified as potential IHR. Of these, 37.1% (184) were suspected to be IgE-mediated, (including anaphylaxis, angioedema and/or urticaria) and 83.5% (414) occurred within 15 minutes of vaccination. The incidence of potential IHR was 5.4 per 100,000 doses, with that of suspected IgE-mediated IHR being 2.0 per 100,000 doses. The incidence of anaphylaxis was extremely low (0.13 per 100,000 doses) and is consistent with other published studies. Potential IHR following immunization should be reported to appropriate local pharmacovigilance systems and patients reviewed by specialists able to evaluate, investigate and manage future vaccinations.

Keywords: adverse events following immunization (AEFI); vaccine allergy; vaccine hypersensitivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adverse Drug Reaction Reporting Systems / statistics & numerical data*
  • Anaphylaxis / epidemiology*
  • Anaphylaxis / immunology
  • Child, Preschool
  • Humans
  • Incidence
  • Pharmacovigilance
  • Vaccination / adverse effects*
  • Vaccination / statistics & numerical data
  • Vaccines / administration & dosage
  • Vaccines / adverse effects*
  • Vaccines / immunology
  • Victoria

Substances

  • Vaccines

Grants and funding

SAEFVIC is funded by the Victorian Department of Health and Human Services. KP is supported by a Melbourne Children's Clinician-Scientist Fellowship. Hazel Clothier is supported by an Australian Government Research Training Program Scholarship.